These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25819524)

  • 1. Galectin expression in cancer diagnosis and prognosis: A systematic review.
    Thijssen VL; Heusschen R; Caers J; Griffioen AW
    Biochim Biophys Acta; 2015 Apr; 1855(2):235-47. PubMed ID: 25819524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
    Bartolazzi A; Sciacchitano S; D'Alessandria C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 is a diagnostic marker involved in thyroid cancer progression.
    Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S
    Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of galectins in cancer: a critical review.
    van den Brûle F; Califice S; Castronovo V
    Glycoconj J; 2002; 19(7-9):537-42. PubMed ID: 14758077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
    Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor galectinology: insights into the complex network of a family of endogenous lectins.
    Lahm H; André S; Hoeflich A; Kaltner H; Siebert HC; Sordat B; von der Lieth CW; Wolf E; Gabius HJ
    Glycoconj J; 2004; 20(4):227-38. PubMed ID: 15115907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varied expression and localization of multiple galectins in different cancer cell lines.
    Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
    Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
    Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
    Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
    Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer.
    Szoke T; Kayser K; Baumhakel JD; Trojan I; Furak J; Tiszlavicz L; Horvath A; Szluha K; Gabius HJ; Andre S
    Oncology; 2005; 69(2):167-74. PubMed ID: 16127288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients.
    Markalunas EG; Arnold DH; Funkhouser AT; Martin JC; Shtutman M; Edenfield WJ; Blenda AV
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of galectin-1 and galectin-3 in human fetal thyroid gland.
    Savin SB; Cvejić DS; Janković MM
    J Histochem Cytochem; 2003 Apr; 51(4):479-83. PubMed ID: 12642626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
    DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
    Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.
    Weissenbacher T; Kuhn C; Mayr D; Pavlik R; Friese K; Scholz C; Jeschke U; Ditsch N; Dian D
    Anticancer Res; 2011 Feb; 31(2):451-7. PubMed ID: 21378323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
    Lahm H; André S; Hoeflich A; Fischer JR; Sordat B; Kaltner H; Wolf E; Gabius HJ
    J Cancer Res Clin Oncol; 2001; 127(6):375-86. PubMed ID: 11414198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Studies on Galectin Expression in Colectomised Patients with Ulcerative Colitis.
    Block M; Mölne J; Leffler H; Börjesson L; Breimer ME
    Biomed Res Int; 2016; 2016():5989128. PubMed ID: 26885508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
    Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
    Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.